Intrinsic Value of S&P & Nasdaq Contact Us

POZEN Inc. POZN NASDAQ

NASDAQ • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
78/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

POZEN Inc. (POZN) trades at a trailing P/E of 9.9. Trailing earnings yield is 10.10%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — P/E is below market average (9.9); earnings yield beats bond yields (10.10%).
  • Trailing Earnings Yield 10.10% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 76/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
78/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
~
PAST
50/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
GROWTH
100/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — POZN

Valuation Multiples
P/E (TTM)9.9
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio6.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.60
Book Value / Share$0.00
Revenue / Share$0.99
FCF / Share$0.00
Yields & Fair Value
Earnings Yield10.10%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2005 $0.07 $28.65M $1.96M 6.8%
2006 $-0.66 $13.52M $-19.31M -142.9%
2007 $0.16 $53.44M $4.67M 8.7%
2008 $-0.20 $66.13M $-5.98M -9%
2009 $-0.27 $32.19M $-8.13M -25.2%
2010 $0.77 $68.55M $23.07M 33.7%
2011 $1.40 $86.95M $42.34M 48.7%
2012 $-0.84 $5.35M $-25.28M -472.7%
2013 $-0.55 $10.32M $-16.71M -161.9%
2014 $0.60 $32.39M $19.68M 60.7%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message